Andrew D. Leavitt, MD

Andrew D. Leavitt, MD

Professor, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF

Phone: (415) 514-3432, 476-4217 (voice)
Box 0100, UCSF
San Francisco, CA 94143-0100

View on UCSF Profiles

Cancer Center Membership

Program Member ยป Hematopoietic Malignancies


University of Michigan, Ann Arbor, B.S., 1979, Zoology
Harvard Medical School, M.D., 1984, Medicine

Professional Experience

  • 1982-1984
    Medical School Research Fellowship, Harvard Medical School, Department of Pediatric Hematology & Oncology (Laboratory of Dr. Robert Garcea; Project: Expression cloning, purification, and characterization of Polyoma major capsid protein, VP1)
  • 1984-1987
    Intern and Resident, Department of Internal Medicine, University of Michigan Hospitals
  • 1987-1988
    Chief Resident, Department of Internal Medicine, University of Michigan Hospitals
  • 1988-1991
    Hematology/Oncology Fellow, University of California, San Francisco
  • 1991-1992
    Molecular Medicine Fellow, University of California, San Francisco
  • 1989-1992
    Post-doctoral Research Fellow, University of California, San Francisco, Department of Microbiology & Immunology (Laboratory of Dr. Harold Varmus; Project: Biochemical characterization of retroviral integration)
  • 1992-2001
    Assistant Professor-in-residence, Department of Laboratory Medicine & Department of Medicine, UCSF
  • 1992-present
    Assistant Director, Blood Bank, Moffit-Long Hospitals, UCSF
  • 1994-present
    Medical Director, Adult Hematopoietic Progenitor Cell & Cellular Therapy Laboratory, Moffitt-Long Hospitals, UCSF
  • 2001-2007
    Associate Professor in Residence, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF
  • 2007-present
    Professor in Residence, Departments of Laboratory Medicine and Medicine (Div. of Hematology/Oncology), UCSF

Honors & Awards

  • 1978-79
    James B. Angell Scholar, University of Michigan
  • 1979
    Phi Beta Kappa, University of Michigan
  • 1982-83
    Karin Grunebaum Cancer Research Foundation Fellowship, Harvard Medical School
  • 1984
    Cum Laude, Harvard Medical School
  • 1985
    Outstanding House Officer Award, Department of Internal Medicine, University of Michigan
  • 1991-92
    Burroughs Wellcome Research Fellowship
  • 1998
    Nomination for Small Group Teaching Award; UCSF Class of 2000
  • 2000
    Nomination for Small Group Teaching and Outstanding Lecture Award; UCSF Class of 2002
  • 2002
    Outstanding Lecture Award; UCSF Class of 2005
  • 2003
    Nominated for Kaiser Award for Excellence in Teaching
  • 2006
    Excellence in Teaching Award from the Haile T. Debas Academy of Medical Educator-UCSF

Selected Publications

  1. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 2015 Jul 2; 17(1):35-46.
    View on PubMed
  2. The Surgical Clerkship and Medical Student Performance in a Standardized Patient Case of Acute Cholecystitis. J Surg Educ. 2015 Sep-Oct; 72(5):1045-51.
    View on PubMed
  3. Shedding a little light on posttransfusion purpura. Transfusion. 2015 Feb; 55(2):232-4.
    View on PubMed
  4. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir Med. 2015 Jan; 3(1):24-32.
    View on PubMed
  5. Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis. Bone Marrow Transplant. 2015 Jan; 50(1):40-4.
    View on PubMed
  6. Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. Ann Intensive Care. 2014; 4:22.
    View on PubMed
  7. Hematopoietic expression of oncogenic BRAF promotes aberrant growth of monocyte-lineage cells resistant to PLX4720. Mol Cancer Res. 2013 Dec; 11(12):1530-41.
    View on PubMed
  8. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report. Transfusion. 2013 Nov; 53(11):2715-21.
    View on PubMed
  9. Widespread RNA 3'-end oligouridylation in mammals. RNA. 2012 Mar; 18(3):394-401.
    View on PubMed
  10. Homologous recombination in human embryonic stem cells: a tool for advancing cell therapy and understanding and treating human disease. Clin Transl Sci. 2011 Aug; 4(4):298-305.
    View on PubMed
  11. Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer. Oncogene. 2011 Oct 27; 30(43):4399-409.
    View on PubMed
  12. A vote for scientists as politicians. Science. 2011 Feb 25; 331(6020):1010.
    View on PubMed
  13. Are there more tricks in the bag for treating thrombocytopenia? J Clin Invest. 2010 Nov; 120(11):3807-10.
    View on PubMed
  14. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev. 2009 Dec; 18(10):1441-50.
    View on PubMed
  15. Catalytically-active complex of HIV-1 integrase with a viral DNA substrate binds anti-integrase drugs. Proc Natl Acad Sci U S A. 2009 May 19; 106(20):8192-7.
    View on PubMed
  16. A method for single-cell sorting and expansion of genetically modified human embryonic stem cells. Stem Cells Dev. 2007 Feb; 16(1):109-17.
    View on PubMed
  17. Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. J Thromb Haemost. 2006 Feb; 4(2):436-42.
    View on PubMed
  18. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost. 2005 Sep; 3(9):2098-101.
    View on PubMed
  19. A critical function for B-Raf at multiple stages of myelopoiesis. Blood. 2005 Aug 1; 106(3):833-40.
    View on PubMed
  20. Caspase-12: a developmental link between G-protein-coupled receptors and integrin alphaIIbbeta3 activation. Blood. 2004 Sep 1; 104(5):1327-34.
    View on PubMed

Go to UCSF Profiles, powered by CTSI